U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name in the U.S. for thalassemia ...

A look at aging baby boomers in the United States

The generation that twirled the first plastic hula hoops, blissed out at Woodstock and protested and fought in Vietnam is now contributing to the aging of America.
Opinion
Council on Foreign RelationsOpinion

The Great Aid Recession: 2025’s Humanitarian Crash in Nine Charts

The world faces unresolved conflicts, growing climate crises, attacks on aid workers, two famines, and diminishing political will—along with significant aid cuts. Altogether, 2025 has earned a grim ...

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia

The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that ...